📑Facteurs de stimulation des colonies de granulocytes (G-CSF)
Procurement process summary
This process is to purchase Facteurs de stimulation des colonies de granulocytes (G-CSF).
This contract was awarded by 🇧🇪 Chirec for an amount of EUR 17,997 to 1 supplier. It was published on 2024-07-10 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇧🇪 Chirec Buying unitnot reported Publication date2024-07-10 Contest statusnot reported DescriptionFacteurs de stimulation des colonies de granulocytes (G-CSF)Awards
This award was granted to Teva Pharma Belgium by Chirec for an amount of EUR 17,997. The procurement process was conducted through open for the category of goods. This is award number 2.
This contract has multiple awards. This is award number 2. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇧🇪 Teva Pharma Belgium | EUR 17,997 | 2 |
Market context and opportunities
The execution of this contract allows the entity Chirec to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberBE_ocds-70d2nz-3a4fdacd-9096-4607-8306-180f714c20ec-award-2Publication date2024-07-10Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailsopenStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
